skip to main content

Amlodipine ankle oedema — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

EasyCardiovascular TherapeuticsAmlodipine ankle oedemaGPhC CRA

A 66-year-old woman develops bilateral ankle swelling two months after increasing amlodipine to 10 mg daily. She has no breathlessness or unilateral calf pain. What would you advise the patient?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: B — Discuss amlodipine-related oedema and arrange prescriber review

This scenario assesses Amlodipine ankle oedema in a UK pharmacy practice context. Peripheral oedema is a common dose-related adverse effect of dihydropyridine calcium-channel blockers. The best answer is Discuss amlodipine-related oedema and arrange prescriber review because it addresses the principal clinical, legal or safety issue before routine supply. The other options are less appropriate because they either miss the key risk, delay necessary review, or would not meet expected BNF, NICE, MEP, MHRA or GPhC practice standards.

Reference: BNF; NICE CKS